Cardiopulmonary

Cardiopulmonary is a unique and challenging area of development, with the majority of cardiopulmonary-related indications encompassing complex and critically ill patient populations. The CTI team includes experienced regulatory and clinical operations personnel who understand the complex and interdependent characteristics of cardiac research. Our familiarity with these unique challenges and interventional treatment experience allows us to efficiently execute these projects. We attend industry meetings and are members of many cardiopulmonary societies, including the International Society for Heart and Lung Transplantation (ISHLT).

We offer our sponsors:

• A history of working in complex and critically ill patient populations
• An employee turnover rate of less than half of the reported industry average, resulting in team continuity
• Experience with first-in-human, first-in-class, and first-in-patient trials
• Personal relationships with key investigators and site personnel
• Executive management involvement on every project
• CTI studies regularly exceed industry standards for enrollment, despite challenging patient populations
• A proven track record of success with more than 100 drug and device approvals